Coast IRB Receives FDA Warning Letter
Coast IRB, an independent institutional review board (IRB) based in Colorado Springs, Colo., received a Warning Letter from the U.S. Food and Drug Administration (FDA) concerning the company’s improper expedited review of a phase I study being conducted in northern California. In an unusual move, the agency has temporarily suspended the IRB’s ability to do expedited reviews.
LabConnect Gains Centralized Pathology Testing with Bostwick Scientific Deal
LabConnect, a clinical trial–focused central laboratory provider based in Seattle, Wash., has inked an agreement with Bostwick Laboratories, adding one of the top anatomic pathology testing companies to its international list of networked labs.
Other breaking news...
Company Profile: An interview with Paul Bishop, managing partner, and Lyle Camblos, managing partner, Atlantic Research Group
To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.